Upstate Active Clinical Trials
Study Title:Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine
Administered to Healthy Children 6 to < 36 Months of Age
What is the purpose of the study? (in Layman's terms, please describe the study)The main purpose of conducting this research study is to see if a full dose (0.5-mL volume) of Fluzone Quadrivalent vaccine is as safe and offers as much protection against flu viruses as the half dose (0.25-mL volume) in children 6 through 35 months of age. Vaccine safety will be measured by watching for any possible reactions to the flu vaccine, including fever.
Upstate Institutional Review Board (IRB) Number:928058
Study/Protocol ID:Study GRC88
Study Phase:Phase IV
Patient Age Group:Children
Principal Investigator:Leonard B Weiner
Who can I contact for more information?
Name: Maureen J Butler